E. Ferrannini and W. Cushman, Diabetes and hypertension: the bad companions, The Lancet, vol.380, issue.9841, pp.601-610, 2012.
DOI : 10.1016/S0140-6736(12)60987-8

D. Conen, P. Ridker, S. Mora, J. Buring, and R. Glynn, Blood pressure and risk of developing type 2 diabetes mellitus: The Women's Health Study, European Heart Journal, vol.28, issue.23, pp.2937-2943, 2007.
DOI : 10.1093/eurheartj/ehm400

T. Gress, F. Nieto, E. Shahar, M. Wofford, and F. Brancati, Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus, New England Journal of Medicine, vol.342, issue.13, pp.905-912, 2000.
DOI : 10.1056/NEJM200003303421301

J. Bjornholt, G. Erikssen, S. Kjeldsen, J. Bodegard, E. Thaulow et al., Fasting blood glucose is independently associated with resting and exercise blood pressures and development of elevated blood pressure, Journal of Hypertension, vol.21, issue.7, pp.1383-1389, 2003.
DOI : 10.1097/00004872-200307000-00029

J. He, M. Klag, B. Caballero, L. Appel, J. Charleston et al., Plasma Insulin Levels and Incidence of Hypertension in African Americans and Whites, Archives of Internal Medicine, vol.159, issue.5, pp.498-503, 1999.
DOI : 10.1001/archinte.159.5.498

A. Fagot-campagna, B. Balkau, D. Simon, P. Ducimetiere, and E. Eschwege, Is insulin an independent risk factor for hypertension? The Paris Prospective Study, International Journal of Epidemiology, vol.26, issue.3, pp.542-550, 1997.
DOI : 10.1093/ije/26.3.542

J. Bower, L. Appel, and K. Matsushita, Glycated Hemoglobin and Risk of Hypertension in the Atherosclerosis Risk in Communities Study, Diabetes Care, vol.35, issue.5, pp.1031-1037, 2012.
DOI : 10.2337/dc11-2248

K. Britton, A. Pradhan, and J. Gaziano, Hemoglobin A1c, Body Mass Index, and the Risk of Hypertension in Women, American Journal of Hypertension, vol.24, issue.3, pp.328-334, 2011.
DOI : 10.1038/ajh.2010.233

A. Gloyn, M. Braun, and P. Rorsman, Type 2 Diabetes Susceptibility Gene TCF7L2 and Its Role in ??-Cell Function, Diabetes, vol.58, issue.4, pp.800-802, 2009.
DOI : 10.2337/db09-0099

J. Florez, K. Jablonski, and N. Bayley, Polymorphisms and Progression to Diabetes in the Diabetes Prevention Program, New England Journal of Medicine, vol.355, issue.3, pp.241-250, 2006.
DOI : 10.1056/NEJMoa062418

S. Hills, B. Balkau, and S. Coppack, The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and Objectives, Diabetologia, vol.47, issue.3, pp.566-570, 2004.
DOI : 10.1007/s00125-004-1335-5

A. Gautier, R. Roussel, and C. Lange, Effects of genetic susceptibility for type 2, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00866193

F. Bonnet, M. Marre, and J. Halimi, Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study, Journal of Hypertension, vol.24, issue.6, pp.1157-1163, 2006.
DOI : 10.1097/01.hjh.0000226206.03560.ac

D. Matthews, J. Hosker, A. Rudenski, B. Naylor, D. Treacher et al., Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, vol.92, issue.7, pp.412-419, 1985.
DOI : 10.1007/BF00280883

B. Antuna-puente, E. Disse, R. Rabasa-lhoret, M. Laville, J. Capeau et al., How can we measure insulin sensitivity/resistance?, Diabetes & Metabolism, vol.37, issue.3, pp.179-188, 2011.
DOI : 10.1016/j.diabet.2011.01.002

F. Bonnet, S. Patel, and M. Laville, Influence of the ACE Gene Insertion/Deletion Polymorphism on Insulin Sensitivity and Impaired Glucose Tolerance in Healthy Subjects, Diabetes Care, vol.31, issue.4, pp.789-794, 2008.
DOI : 10.2337/dc07-1788

F. Bonnet, E. Disse, and M. Laville, Moderate alcohol consumption is associated with improved insulin sensitivity, reduced basal insulin secretion rate and lower fasting glucagon concentration in healthy women, Diabetologia, vol.84, issue.12, pp.3228-3237, 2012.
DOI : 10.1007/s00125-012-2701-3
URL : https://hal.archives-ouvertes.fr/hal-00866010

C. Craig, A. Marshall, and M. Sjostrom, International Physical Activity Questionnaire: 12-Country Reliability and Validity, Medicine & Science in Sports & Exercise, vol.35, issue.8, pp.1381-1395, 2003.
DOI : 10.1249/01.MSS.0000078924.61453.FB

E. Van-cauter, F. Mestrez, J. Sturis, and K. Polonsky, Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance, Diabetes, vol.41, issue.3, pp.368-377, 1992.
DOI : 10.2337/diabetes.41.3.368

A. Mari, O. Schmitz, A. Gastaldelli, T. Oestergaard, B. Nyholm et al., Meal and oral glucose tests for assessment of ??-cell function: modeling analysis in normal subjects, American Journal of Physiology - Endocrinology And Metabolism, vol.283, issue.6, pp.1159-1166, 2002.
DOI : 10.1152/ajpendo.00093.2002

A. Mari, A. Tura, and A. Natali, Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance, Diabetologia, vol.104, issue.Suppl 4, pp.749-756, 2010.
DOI : 10.1007/s00125-009-1647-6

O. Rahilly, S. Turner, R. Matthews, and D. , Impaired Pulsatile Secretion of Insulin in Relatives of Patients with Non-Insulin-Dependent Diabetes, New England Journal of Medicine, vol.318, issue.19, pp.1225-1230, 1988.
DOI : 10.1056/NEJM198805123181902

J. Meigs, L. Cupples, and P. Wilson, Parental transmission of type 2 diabetes: the Framingham Offspring Study, Diabetes, vol.49, issue.12, pp.2201-2207, 2000.
DOI : 10.2337/diabetes.49.12.2201

R. Bonadonna, M. Stumvoll, and A. Fritsche, Altered Homeostatic Adaptation of First- and Second-Phase ??-Cell Secretion in the Offspring of Patients With Type 2 Diabetes: Studies With a Minimal Model to Assess ??-Cell Function, Diabetes, vol.52, issue.2, pp.470-480, 2003.
DOI : 10.2337/diabetes.52.2.470

I. Vauhkonen, L. Niskanen, E. Vanninen, S. Kainulainen, M. Uusitupa et al., Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands., Journal of Clinical Investigation, vol.101, issue.1, pp.86-96, 1998.
DOI : 10.1172/JCI716

S. Frontoni, D. Bracaglia, and A. Baroni, Early Autonomic Dysfunction in Glucose-Tolerant but Insulin-Resistant Offspring of Type 2 Diabetic Patients, Hypertension, vol.41, issue.6, pp.1223-1227, 2003.
DOI : 10.1161/01.HYP.0000073062.29546.01

S. Haffner, M. Stern, H. Hazuda, B. Mitchell, J. Patterson et al., Parental history of diabetes is associated with increased cardiovascular risk factors, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.9, issue.6, pp.928-933, 1989.
DOI : 10.1161/01.ATV.9.6.928

A. Pontiroli, L. Monti, A. Pizzini, and P. Piatti, Familial clustering of arterial blood pressure, HDL cholesterol, and pro-insulin but not of insulin resistance and microalbuminuria in siblings of patients with type 2 diabetes, Diabetes Care, vol.23, issue.9, pp.1359-1364, 2000.
DOI : 10.2337/diacare.23.9.1359

S. Srinivasan, M. Frontini, and G. Berenson, Longitudinal changes in risk variables of insulin resistance syndrome from childhood to young adulthood in offspring of parents with type 2 diabetes: The Bogalusa Heart Study, Metabolism, vol.52, issue.4, pp.443-450, 2003.
DOI : 10.1053/meta.2003.50065

J. Florez, Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: Where are the insulin resistance genes?, Diabetologia, vol.8, issue.7, pp.1100-1110, 2008.
DOI : 10.1007/s00125-008-1025-9

A. Drong, C. Lindgren, and M. Mccarthy, The Genetic and Epigenetic Basis of Type 2 Diabetes and Obesity, Clinical Pharmacology & Therapeutics, vol.316, issue.6, pp.707-715, 2012.
DOI : 10.1086/518517

S. Cauchi, D. Meyre, and H. Choquet, TCF7L2 Variation Predicts Hyperglycemia Incidence in a French General Population: The Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) Study, Diabetes, vol.55, issue.11, pp.3189-3192, 2006.
DOI : 10.2337/db06-0692
URL : https://hal.archives-ouvertes.fr/hal-00126954

V. Lyssenko, R. Lupi, and P. Marchetti, Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes, Journal of Clinical Investigation, vol.117, issue.8, pp.2155-2163, 2007.
DOI : 10.1172/JCI30706DS1

D. Villareal, H. Robertson, and G. Bell, TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action, Diabetes, vol.59, issue.2, pp.479-485, 2010.
DOI : 10.2337/db09-1169

P. Yerram and A. Whaley-connell, Novel role for the incretins in blood pressure regulation. Current opinion in nephrology and hypertension, pp.463-468, 2012.

V. Gupta, R. Khadgawat, and H. Ng, Association of TCF7L2 and ADIPOQ with Body Mass Index, Waist???Hip Ratio, and Systolic Blood Pressure in an Endogamous Ethnic Group of India, Genetic Testing and Molecular Biomarkers, vol.16, issue.8, pp.948-951, 2012.
DOI : 10.1089/gtmb.2012.0051

G. Ehret, P. Munroe, and K. Rice, Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk, Nature, vol.43, issue.7367, pp.103-109, 2011.
DOI : 10.1038/nature10405

J. Arnlov, M. Pencina, and B. Nam, Relations of Insulin Sensitivity to Longitudinal Blood Pressure Tracking: Variations With Baseline Age, Body Mass Index, and Blood Pressure, Circulation, vol.112, issue.12, pp.1719-1727, 2005.
DOI : 10.1161/CIRCULATIONAHA.105.535039

A. Liese, E. Mayer-davis, and L. Chambless, Elevated fasting insulin predicts incident hypertension, Journal of Hypertension, vol.17, issue.8, pp.1169-1177, 1999.
DOI : 10.1097/00004872-199917080-00017

P. Xun, K. Liu, W. Cao, S. Sidney, O. Williams et al., Fasting Insulin Level Is Positively Associated With Incidence of Hypertension Among American Young Adults: A 20-year follow-up study, Diabetes Care, vol.35, issue.7, pp.1532-1537, 2012.
DOI : 10.2337/dc11-2443

T. Heise, K. Magnusson, L. Heinemann, and P. Sawicki, Insulin Resistance and the Effect of Insulin on Blood Pressure in Essential Hypertension, Hypertension, vol.32, issue.2, pp.243-248, 1998.
DOI : 10.1161/01.HYP.32.2.243

C. Rask-madsen, Q. Li, and B. Freund, Loss of Insulin Signaling in Vascular Endothelial Cells Accelerates Atherosclerosis in Apolipoprotein E Null Mice, Cell Metabolism, vol.11, issue.5, pp.379-389, 2010.
DOI : 10.1016/j.cmet.2010.03.013

E. Galkina, M. Butcher, and S. Keller, Accelerated Atherosclerosis in Apoe-/- Mice Heterozygous for the Insulin Receptor and the Insulin Receptor Substrate-1, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.32, issue.2, pp.247-256, 2012.
DOI : 10.1161/ATVBAHA.111.240358

G. Mistry, A. Maes, and K. Lasseter, Effect of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Blood Pressure in Nondiabetic Patients With Mild to Moderate Hypertension, The Journal of Clinical Pharmacology, vol.45, issue.Suppl 1, pp.592-598, 2008.
DOI : 10.1177/0091270008316885

S. Koren, L. Shemesh-bar, and A. Tirosh, The Effect of Sitagliptin Versus Glibenclamide on Arterial Stiffness, Blood Pressure, Lipids, and Inflammation in Type 2 Diabetes Mellitus Patients, Diabetes Technology & Therapeutics, vol.14, issue.7, pp.561-567, 2012.
DOI : 10.1089/dia.2011.0296

D. Cherney, J. Scholey, E. Sochett, T. Bradley, and H. Reich, The Acute Effect of Clamped Hyperglycemia on the Urinary Excretion of Inflammatory Cytokines/Chemokines in Uncomplicated Type 1 Diabetes: A pilot study, Diabetes Care, vol.34, issue.1, pp.177-180, 2011.
DOI : 10.2337/dc10-1219

L. Monnier, E. Mas, and C. Ginet, Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes, JAMA, vol.295, issue.14, 2006.
DOI : 10.1001/jama.295.14.1681

D. Flaviani, A. Picconi, F. , D. Stefano, and P. , Impact of Glycemic and Blood Pressure Variability on Surrogate Measures of Cardiovascular Outcomes in Type 2 Diabetic Patients, Diabetes Care, vol.34, issue.7, pp.1605-1609, 2011.
DOI : 10.2337/dc11-0034